Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Cellular immunotherapy is becoming a new pillar in cancer treatment after recent striking results in different clinical trials with chimeric antigen receptor T cells. However, this innovative therapy is not exempt from challenges such as off-tumor toxicity, tumor recurrence in heterogeneous tumors,...

Full description

Bibliographic Details
Main Authors: Benjamin Motais, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giebel, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Jiří Sobotka, Zdeněk Kořístek, Roman Hájek, Juli R. Bagó
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cells
Subjects:
cancer
natural killers
cellular therapy
monoclonal antibodies
multiple myeloma
combination therapy
Online Access:https://www.mdpi.com/2073-4409/10/5/967

Internet

https://www.mdpi.com/2073-4409/10/5/967

Similar Items